tradingkey.logo

tradingkey.logo
怜玢


Lexaria Bioscience Corp

LEXX
りォッチリストに远加
4.440USD
+0.260+6.22%
終倀 11-13 16:00ET
9.37M時䟡総額
損倱額盎近12ヶ月PER

Lexaria Bioscience Corpに぀いお 䌁業名

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery formulation and processing platform technology improves the way a wide variety of drugs enter the bloodstream, always through oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. The Company’s segment includes Intellectual Property, B2B Production, and Research and Development. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its focus is the investigation and the incorporation of its DehydraTECH drug delivery technology with glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) to enhance absorption and reduce adverse side effects. The Company operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 48 patents granted and many patents pending worldwide.

Lexaria Bioscience Corp プロフィヌル


䌁業コヌドLEXX
䌚瀟名Lexaria Bioscience Corp
䞊堎日Oct 28, 2009
最高経営責任者「CEO」Christopher (Richard)
埓業員数7
蚌刞皮類Ordinary Share
決算期末Oct 28
本瀟所圚地100 - 740 Mccurdy Road
郜垂KELOWNA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Canada
郵䟿番号V1X 2P7
電話番号12507656424
りェブサむトhttps://www.lexariabioscience.com/
䌁業コヌドLEXX
䞊堎日Oct 28, 2009
最高経営責任者「CEO」Christopher (Richard)

Lexaria Bioscience Corpの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Christopher A. (Chris) Bunka
Mr. Christopher A. (Chris) Bunka
Chairman of the Board
Chairman of the Board
37.03K
-18.00%
Mr. Christopher A. (Chris) Bunka
Mr. Christopher A. (Chris) Bunka
Chairman of the Board
Chairman of the Board
37.03K
-18.00%
Mr. Christopher A. (Chris) Bunka
Mr. Christopher A. (Chris) Bunka
Chairman of the Board
Chairman of the Board
37.03K
-18.00%
Mr. John Martin Docherty
Mr. John Martin Docherty
President, Director
President, Director
3.96K
--
Mr. John Martin Docherty
Mr. John Martin Docherty
President, Director
President, Director
3.96K
--
Mr. John Martin Docherty
Mr. John Martin Docherty
President, Director
President, Director
3.96K
--
Mr. Nicholas W. (Nick) Baxter
Mr. Nicholas W. (Nick) Baxter
Independent Director
Independent Director
733.00
--
Mr. Nicholas W. (Nick) Baxter
Mr. Nicholas W. (Nick) Baxter
Independent Director
Independent Director
733.00
--
Mr. Nicholas W. (Nick) Baxter
Mr. Nicholas W. (Nick) Baxter
Independent Director
Independent Director
733.00
--
Mr. Richard Christopher
Mr. Richard Christopher
Chief Executive Officer
Chief Executive Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Christopher A. (Chris) Bunka
Mr. Christopher A. (Chris) Bunka
Chairman of the Board
Chairman of the Board
37.03K
-18.00%
Mr. Christopher A. (Chris) Bunka
Mr. Christopher A. (Chris) Bunka
Chairman of the Board
Chairman of the Board
37.03K
-18.00%
Mr. Christopher A. (Chris) Bunka
Mr. Christopher A. (Chris) Bunka
Chairman of the Board
Chairman of the Board
37.03K
-18.00%
Mr. John Martin Docherty
Mr. John Martin Docherty
President, Director
President, Director
3.96K
--
Mr. John Martin Docherty
Mr. John Martin Docherty
President, Director
President, Director
3.96K
--
Mr. John Martin Docherty
Mr. John Martin Docherty
President, Director
President, Director
3.96K
--

よくある質問

Lexaria Bioscience Corpの䞊䜍5名の株䞻は誰ですか


Lexaria Bioscience Corpの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Christopher A. (Chris) Bunka

Lexaria Bioscience CorpLEXXの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Lexaria Bioscience Corpの株匏を保有しおいる機関は54瀟あり、保有株匏の総垂堎䟡倀は玄1.64Mで、党䜓の6.61%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-2368419.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。